Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
After excluding those taking B12 and those already known to have cancer, 250 patients were followed for roughly two years
After 28 days, the risk of bacterial growth increases, even if the medication itself is still chemically stable
Users with a history of multiple endocrine neoplasia syndrome or endocrine neoplasia syndrome type should discuss their options with a healthcare provider before starting treatment
Key safety principles include: Never share syringes, needles, or vials with another person Always use a new, sterile syringe for each injection Maintain strict hand hygiene and site cleaning protocols Store and dispose of sharps according to local regulations Don't inject into areas with visible infection, inflammation, rashes, or moles Contact your physician if you notice signs of infection at an injection site (increasing redness, warmth, swelling, or discharge) AOD-9604 itself has a well-established safety profile at therapeutic doses
Pinheiro MM et al
Compound Overview & Target Pathways This blend pairs BPC-157 with TB-500, a synthetic peptide fragment commonly associated with thymosin beta-4 pathway models
